Last updated on July 2018

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease in Asia Pacific

Brief description of study

Since the infectious aetiology of AECOPD has been suggested to vary according to geographical region, the primary purpose of this study (which will be conducted in several countries in Asia Pacific) is to evaluate the occurrence of bacterial and viral pathogens in the sputum of stable COPD patients and at the time of AECOPD. Given the increasing and projected burden of COPD in the Asia Pacific region, this study will also evaluate the frequency, severity and duration of AECOPD, as well as the impact of AECOPD on health-related quality of life (HRQOL), healthcare utilisation and lung function.

Detailed Study Description

The protocol has been amended to implement the following changes:

  • Alignment of the protocol to the updated GOLD consensus report of 2017 and the COPD fact sheet.
  • Alignment of the study endpoints to the study objectives.

Clinical Study Identifier: NCT03151395

Contact Investigators or Research Sites near you

Start Over

US GSK Clinical Trials Call ...

GSK Investigational Site
Wonju, Gangwon-do,, Korea, Republic of
  Connect »